Inflammation in neurological disorders: A help or a hindrance?

Neuroscientist

Volumn 16, Issue 4, 2010, Pages 408-420

  Wee Yong, V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

neuroinflammation; neuroprotection; remyelination; repair

Indexed keywords

ALZHEIMER DISEASE; CELL ACTIVATION; CELL INFILTRATION; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; STEM CELL MOBILIZATION; T LYMPHOCYTE SUBPOPULATION;

BRAIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NERVE REGENERATION; NERVOUS SYSTEM DISEASES;

EID: 77956302879     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858410371379     Document Type: Review

References (60)

1. Arnett HA, Mason J., Marino M., Suzuki K., Matsushima GK, Ting JP 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4 (11). 1116-1122.
2. Baron R., Nemirovsky A., Harpaz I., Cohen H., Owens T., Monsonego A. 2008. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimerg'ss disease. FASEB J 22 (8). 2843-2852.
3. Bieber AJ, Kerr S., Rodriguez M. 2003. Efficient central nervous system remyelination requires T cells. Ann Neurol 53 (5). 680-684.
4. Chen Q., Smith GM, Shine HD 2008. Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp Neurol 209 (2). 497-509.
5. Danilov AI, Covacu R., Moe MC, Langmoen IA, Johansson CB, Olsson T., and others. 2006. Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis. Eur J Neurosci 23 (2). 394-400.
6. DaSilva AG, Yong VW 2008. Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J Neuroimmunol 199 (1-2). 24-34.
7. David S., Bouchard C., Tsatas O., Giftochristos N. 1990. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5 (4). 463-469.
8. Ferguson B., Matyszak MK, Esiri MM, Perry VH 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3). 393-399.
9. Foote AK, Blakemore WF 2005. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 (Pt 3). 528-539.
10. Giuliani F., Goodyer CG, Antel JP, Yong VW 2003. Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 171 (1). 368-379.
11. Glass CK, Saijo K., Winner B., Marchetto MC, Gage FH 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
12. Graber JJ, Dhib-Jalbut S. 2009. Protective autoimmunity in the nervous system. Pharmacol Ther 121 (2). 147-159.
13. Hammarberg H., Lidman O., Lundberg C., Eltayeb SY, Gielen AW, Muhallab S., and others. 2000. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20 (14). 5283-5291.
14. Hendrix S., Nitsch R. 2007. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 184 (1-2). 100-112.
15. Herx LM, Rivest S., Yong VW 2000. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 165 (4). 2232-2239.
16. Hirsch EC, Hunot S. 2009. Neuroinflammation in Parkinsong'ss disease: a target for neuroprotection? Lancet Neurol 8 (4). 382-397.
17. Imitola J., Raddassi K., Park KI, Mueller FJ, Nieto M., Teng YD, and others. 2004. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 (52). 18117-18122.
18. Irvine KA, Blakemore WF 2008. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131(Pt 6). 1464-1477.
19. Jones TB, Ankeny DP, Guan Z., McGaughy V., Fisher LC, Basso DM, and others. 2004. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci 24 (15). 3752-3761.
20. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., and others. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13 (10). 1173-1175.
21. Kerschensteiner M., Meinl E., Hohlfeld R. 2009. Neuro-immune crosstalk in CNS diseases. Neuroscience 158 (3). 1122-1132.
22. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29 (43). 13435-13444.
23. Kigerl KA, Lai W., Rivest S., Hart RP, Satoskar AR, Popovich PG 2007. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 102 (1). 37-50.
24. Kotter MR, Zhao C., van Rooijen N., Franklin RJ 2005. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18 (1). 166-175.
25. Lalancette-Hebert M., Gowing G., Simard A., Weng YC, Kriz J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27 (10). 2596-2605.
26. Larsen PH, Wells JE, Stallcup WB, Opdenakker G., Yong VW 2003. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23 (35). 11127-11135.
27. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW 2004. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89 (5). 1092-1100.
28. Loughlin AJ, Copelman CA, Hall A., Armer T., Young BC, Landon DN, and others. 1997. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J Neurosci Res 47 (4). 384-392.
29. Martinez FO, Helming L., Gordon S. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483.
30. Medana I., Li Z., Flugel A., Tschopp J., Wekerle H., Neumann H. 2001. Fas ligand (CD95L) protects neurons against perforinmediated T lymphocyte cytotoxicity. J Immunol 167 (2). 674-681.
31. Nahrendorf M., Swirski FK, Aikawa E., Stangenberg L., Wurdinger T., Figueiredo JL, and others. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204 (12). 3037-3047.
32. Neumann H., Kotter MR, Franklin RJ 2009. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132 (Pt 2). 288-295.
33. Nimmerjahn A., Kirchhoff F., Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (5726). 1314-1318.
34. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., and others. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 (Pt 12). 3165-3172.
35. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., and others. 1999. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25 (4). 343-357.
36. Popovich PG, Longbrake EE 2008. Can the immune system be harnessed to repair the CNS ? Nat Rev Neurosci 9 (6). 481-493.
37. Prewitt CM, Niesman IR, Kane CJ, Houle JD 1997. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 148 (2). 433-443.
38. Rice T., Larsen J., Rivest S., Yong VW 2007. Characterization of the early neuroinflammation after spinal cord injury in mice. J Neuropathol Exp Neurol 66 (3). 184-195.
39. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., and others. 2007. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 9 (9). 1081-1088.
40. Schwartz M., Moalem G., Leibowitz-Amit R., Cohen IR 1999. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci 22 (7). 295-299.
41. Setzu A., Lathia JD, Zhao C., Wells K., Rao MS, Ffrench-Constant C., and others. 2006. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (4). 297-303.
42. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., and others. 2009. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6 (7). e1000113.
43. Simard AR, Soulet D., Gowing G., Julien JP, Rivest S. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimerg'ss disease. Neuron 49 (4). 489-502.
44. Skihar V., Silva C., Chojnacki A., Doring A., Stallcup WB, Weiss S., and others. 2009. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc Natl Acad Sci U S A 106 (42). 17992-17997.
45. Stirling DP, Liu S., Kubes P., Yong VW 2009. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci 29 (3). 753-764.
46. Takeuchi H. 2010. Neurotoxicity by microglia: mechanisms and potential therapeutic strategy. Clin Exp Neuroimmunol 1: 12-21.
47. Turrin NP, Rivest S. 2006. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 26 (1). 143-151.
48. Walton NM, Sutter BM, Laywell ED, Levkoff LH, Kearns SM, Marshall GP 2nd, and others. 2006. Microglia instruct sub-ventricular zone neurogenesis. Glia 54 (8). 815-825.
49. Weber MS, Prodg'shomme T., Youssef S., Dunn SE, Rundle CD, Lee L., and others. 2007. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13 (8). 935-943.
50. Wolf SA, Fisher J., Bechmann I., Steiner B., Kwidzinski E., Nitsch R. 2002. Neuroprotection by T-cells depends on their subtype and activation state. J Neuroimmunol 133 (1-2). 72-80.
51. Xue M., Fan Y., Liu S., Zygun DA, Demchuk A., Yong VW 2009. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain 132 (Pt 1). 26-36.
52. Yin Y., Cui Q., Gilbert HY, Yang Y., Yang Z., Berlinicke C., and others. 2009. Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci U S A 106 (46). 19587-19592.
53. Yin Y., Henzl MT, Lorber B., Nakazawa T., Thomas TT, Jiang F., and others. 2006. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci 9 (6). 843-852.
54. Yong V., Ransohoff RM 2002. Inflammatory cytokines in CNS trauma. In: Feuerstein G, editor. Inflammation and stroke. Basel: Birkhauser Verlag. p 181-192.
55. Yong VW 2002. Differential mechanisms of action of interferon-beta and glatiramer aetate in MS. Neurology 59 (6). 802-808.
56. Yong VW 2004. Prospects for neuroprotection in multiple sclerosis. Front Biosci 9: 864-872.
57. Yong VW, Wells J., Giuliani F., Casha S., Power C., Metz LM 2004. The promise of minocycline in neurology. Lancet Neurol 3 (12). 744-751.
58. Zhao BQ, Wang S., Kim HY, Storrie H., Rosen BR, Mooney DJ, and others. 2006. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12 (4). 441-445.
59. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., and others. 2006. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adult-hood. Nat Neurosci 9 (2). 268-275.
60. Zivadinov R., Reder AT, Filippi M., Minagar A., Stuve O., Lassmann H., and others. 2008. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 71 (2). 136-144.